Canada markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5000+0.0400 (+1.63%)
At close: 04:00PM EDT
2.4900 -0.01 (-0.40%)
After hours: 07:53PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
83,155
61,904
173,314
183,351
-
Other Short Term Investments
365,542
455,416
283,988
644,559
-
Total Cash
448,697
517,320
457,302
827,910
-
Other Current Assets
10,418
11,504
14,021
-
-
Total Current Assets
459,115
528,824
471,323
845,130
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
214,265
233,316
204,381
173,043
-
Accumulated Depreciation
-51,084
-36,885
-23,361
-12,908
-
Net property, plant and equipment
163,181
196,431
181,020
160,135
-
Equity and other investments
3,645
76,468
382,378
207,946
-
Intangible Assets
-
-
-
-
151
Other long-term assets
16,896
19,856
16,107
14,618
-
Total non-current assets
183,722
292,755
579,505
382,699
-
Total Assets
642,837
821,579
1,050,828
1,227,829
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
5,897
13,890
10,255
10,390
-
Accrued liabilities
11,656
15,806
18,170
28,995
-
Deferred revenues
86
95
156
38,992
-
Other Current Liabilities
-
-
-
2,842
2,843
Total Current Liabilities
37,079
53,728
47,907
94,320
-
Non-current liabilities
Other long-term liabilities
5,179
5,847
7,792
3,083
-
Total non-current liabilities
93,525
100,969
77,721
53,892
-
Total Liabilities
130,604
154,697
125,628
148,212
-
Stockholders' Equity
Common Stock
169
144
142
140
-
Retained Earnings
-1,562,233
-1,234,968
-894,554
-646,343
-
Accumulated other comprehensive income
-955
-9,926
-2,567
268
-
Total stockholders' equity
512,233
666,882
925,200
1,079,617
-
Total liabilities and stockholders' equity
642,837
821,579
1,050,828
1,227,829
-